Cite
Postoperative use of somatostatin analogs and mortality in patients with acromegaly
MLA
Wim J. Sluiter, et al. “Postoperative Use of Somatostatin Analogs and Mortality in Patients with Acromegaly.” European Journal of Endocrinology, vol. 180, Jan. 2019, pp. 1–9. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d59dd8329bc0a055cf4e379b17bb0329&authtype=sso&custid=ns315887.
APA
Wim J. Sluiter, André P van Beek, Margreet A E M Wagenmakers, Ad R. M. M. Hermus, Bruce H. R. Wolffenbuttel, Thalijn L C Wolters, Antonius E. van Herwaarden, Gerrit van den Berg, Romana T. Netea-Maier, Anneke C. Muller Kobold, Mark R Postma, & Alfons C.M. van den Bergh. (2019). Postoperative use of somatostatin analogs and mortality in patients with acromegaly. European Journal of Endocrinology, 180, 1–9.
Chicago
Wim J. Sluiter, André P van Beek, Margreet A E M Wagenmakers, Ad R. M. M. Hermus, Bruce H. R. Wolffenbuttel, Thalijn L C Wolters, Antonius E. van Herwaarden, et al. 2019. “Postoperative Use of Somatostatin Analogs and Mortality in Patients with Acromegaly.” European Journal of Endocrinology 180 (January): 1–9. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d59dd8329bc0a055cf4e379b17bb0329&authtype=sso&custid=ns315887.